People living with sickle cell are apprehensive about a revolutionary new one-off treatment that has just been approved for use on the NHS. | ITV News Granada ...
Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...
Hosted on MSN23h
NHS England to offer Casgevy for sickle cell disease patientsCharity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback